
Ab&b Bio-Tech
Stage
Series C | AliveTotal Raised
$92.73MLast Raised
$92.73M | 2 yrs agoAbout Ab&b Bio-Tech
Ab&b Bio-Tech is committed to the research and development, registration and industrial production, and sales of innovative human vaccines, aiming at international standards, replacing imports, and realizing exports.
Ab&b Bio-Tech Frequently Asked Questions (FAQ)
Where is Ab&b Bio-Tech's headquarters?
Ab&b Bio-Tech's headquarters is located at No. 32, Xinglin Road, Medical High-tech Zone, Taizhou.
What is Ab&b Bio-Tech's latest funding round?
Ab&b Bio-Tech's latest funding round is Series C.
How much did Ab&b Bio-Tech raise?
Ab&b Bio-Tech raised a total of $92.73M.
Who are the investors of Ab&b Bio-Tech?
Investors of Ab&b Bio-Tech include Zhuzhou SAH Innovation & Entrepreneur Investment, Green Pine Capital Partners, Wenzhou Investment, CS Capital, Qian Dao Fund and 15 more.